Extensive research is still required to understand the role of TRX in hypoxia and renal disease, nonetheless the characterization of secreted TRX profiles in CKD and RCC patients, similarly to miRNAs, may prove a valuable tool to discriminate between both pathologies at an early stage. Here, TXN is linked to renal cell carcinoma.